Cargando…

Prognosis stratification and personalized treatment in bladder cancer through a robust immune gene pair‐based signature

Detalles Bibliográficos
Autores principales:	Lu, Xiaofan, Meng, Jialin, Zhu, Junkai, Zhou, Yujie, Jiang, Liyun, Wang, Yang, Wen, Weiheng, Liang, Chaozhao, Yan, Fangrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214857/ https://www.ncbi.nlm.nih.gov/pubmed/34185409 http://dx.doi.org/10.1002/ctm2.453

Ejemplares similares

Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
por: Lu, Xiaofan, et al.
Publicado: (2021)

Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma
por: Chen, Yi, et al.
Publicado: (2022)

Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy
por: Meng, Jialin, et al.
Publicado: (2021)

Integrated multi‐omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer
por: Meng, Jialin, et al.
Publicado: (2021)

Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel‐like factors in prostate cancer
por: Meng, Jialin, et al.
Publicado: (2020)

Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Bladder Cancer
por: Huang, Mengjia, et al.
Publicado: (2021)

Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy
por: Bian, Zichen, et al.
Publicado: (2022)

Epigenetic age acceleration of cervical squamous cell carcinoma converged to human papillomavirus 16/18 expression, immunoactivation, and favourable prognosis
por: Lu, Xiaofan, et al.
Publicado: (2020)

A signature of immune-related gene pairs (IRGPs) for risk stratification and prognosis of oral cancer patients
por: Yu, Yanling, et al.
Publicado: (2022)

Tumour microenvironment‐based molecular profiling reveals ideal candidates for high‐grade serous ovarian cancer immunotherapy
por: Lu, Xiaofan, et al.
Publicado: (2021)

Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer
por: Chen, Jia, et al.
Publicado: (2022)

Identification and validation of an inflammation-related lncRNAs signature for improving outcomes of patients in colorectal cancer
por: Huang, Mengjia, et al.
Publicado: (2022)

A robust signature of immune‐related long non‐coding RNA to predict the prognosis of bladder cancer
por: Lai, Cong, et al.
Publicado: (2021)

RNA processing genes characterize RNA splicing and further stratify colorectal cancer
por: Lu, Xiaofan, et al.
Publicado: (2020)

Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients
por: Bian, Zichen, et al.
Publicado: (2021)

Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy
por: Ge, Qintao, et al.
Publicado: (2023)

Continuously available ratio of SpO(2)/FiO(2) serves as a noninvasive prognostic marker for intensive care patients with COVID-19
por: Lu, Xiaofan, et al.
Publicado: (2020)

Macrophages and monocytes mediated activation of oxidative phosphorylation implicated the prognosis and clinical therapeutic strategy of Wilms tumour
por: Meng, Jialin, et al.
Publicado: (2022)

Immune response drives outcomes in prostate cancer: implications for immunotherapy
por: Meng, Jialin, et al.
Publicado: (2020)

Novel immune‐related signature for risk stratification and prognosis in prostatic adenocarcinoma
por: Zhao, Hai‐Bo, et al.
Publicado: (2021)

Individualized prognosis stratification in muscle invasive bladder cancer: A pairwise TP53-derived transcriptome signature
por: Liu, Hua-Ping, et al.
Publicado: (2023)

Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
por: Meng, Jialin, et al.
Publicado: (2022)

Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma
por: Li, Quanxiao, et al.
Publicado: (2021)

The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma
por: Tang, Bufu, et al.
Publicado: (2020)

Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma
por: Liang, Fangfang, et al.
Publicado: (2021)

Immune Microenvironment Terms Signature Robustly Predicts the Prognosis and Immunotherapy Response in Bladder Cancer Based on Large Population Cohorts
por: Liang, Shengjie, et al.
Publicado: (2022)

Advances in risk stratification of bladder cancer to guide personalized medicine
por: Matulay, Justin T., et al.
Publicado: (2018)

Prognostic Implications of Immune-Related Gene Pairs Signatures in Bladder Cancer
por: Xiong, Hui, et al.
Publicado: (2021)

A Pre-operative Nomogram for Prediction of Lymph Node Metastasis in Bladder Urothelial Carcinoma
por: Lu, Xiaofan, et al.
Publicado: (2019)

Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome()
por: Lu, Xiaofan, et al.
Publicado: (2019)

Identification of an immune-related risk signature for predicting prognosis in clear cell renal cell carcinoma
por: Hua, Xiaoliang, et al.
Publicado: (2020)

A Novel Immune-Gene Pair Signature Revealing the Tumor Microenvironment Features and Immunotherapy Prognosis of Muscle-Invasive Bladder Cancer
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer
por: Fei, Hongjun, et al.
Publicado: (2023)

An Immune-Related Gene Pairs Signature Predicts Prognosis and Immune Heterogeneity in Glioblastoma
por: Zhang, Nijia, et al.
Publicado: (2021)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

Stromal-Immune Score-Based Gene Signature: A Prognosis Stratification Tool in Gastric Cancer
por: Wang, Hao, et al.
Publicado: (2019)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

A robust immune-related gene pairs signature for predicting the overall survival of esophageal cancer
por: Zheng, Wei, et al.
Publicado: (2023)

A zinc finger protein gene signature enables bladder cancer treatment stratification
por: Zhang, Jiandong, et al.
Publicado: (2021)

Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas
por: Menor, Mark, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_maih0ir86i4d9scal0ddovc906